Literature DB >> 24931900

The effect of an outpatient care on-demand-system on health status and costs in patients with COPD. A randomized trial.

Farida F Berkhof1, Anne M Hesselink2, Dominique L C Vaessen3, Steven M Uil4, Huib A M Kerstjens5, Jan W K van den Berg6.   

Abstract

BACKGROUND: Traditionally, outpatient visits for COPD are fixed, pre-planned by the pulmonologist. This is not a patient centered method, nor, in times of increasing COPD prevalence and resource constraints, perhaps the optimal method.
OBJECTIVES: This pilot study, determined the effect of an on-demand-system, patient initiated outpatient visits, on health status, COPD-related healthcare resource-use and costs.
METHODS: Patients were randomized between on-demand-system (n = 49) and usual care (n = 51), with a 2-year follow-up. Primary, health status was assessed with Clinical COPD Questionnaire (CCQ). Secondary endpoints were: St. George's Respiratory Questionnaire (SGRQ), Short Form-36 (SF-36) scores, visits to general practitioners (GP), pulmonologists, and pulmonary nurse practitioners (PNP), exacerbations and total treatment costs from healthcare providers and healthcare insurance perspectives.
RESULTS: Participants had a mean FEV(1) 1.3 ± 0.4 liters and were 69 ± 9 years. CCQ total scores deteriorated in both groups, with no significant difference between them. CCQ symptom domain did show a significant and clinically relevant difference in favor of the on-demand-group, -0.4 ± 0.21, CI95% -0.87; -0.02, p = 0.04. Similar tendency was found for the SGRQ whereas results for SF-36 were inconsistent. Patients in the on-demand-group visited GP significantly less (p = 0.01), but PNP significantly more, p = 0.003. Visits to pulmonologists and exacerbations were equally frequent in both groups. Mean total costs per patient were lower in the on-demand-group in comparison with usual care, difference of €-518 (-1993; 788) from healthcare provider and €-458 (-2700; 1652) insurance perspective.
CONCLUSIONS: The on-demand-system was comparable with usual care, had a cost-saving tendency, and can be instituted with confidence in the COPD outpatient care setting.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CCQ; Healthcare costs; On-demand-system; Resource-use

Mesh:

Year:  2014        PMID: 24931900     DOI: 10.1016/j.rmed.2014.05.011

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  5 in total

Review 1.  Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.

Authors:  Anke Lenferink; Marjolein Brusse-Keizer; Paul Dlpm van der Valk; Peter A Frith; Marlies Zwerink; Evelyn M Monninkhof; Job van der Palen; Tanja W Effing
Journal:  Cochrane Database Syst Rev       Date:  2017-08-04

Review 2.  Self-management interventions for people with chronic obstructive pulmonary disease.

Authors:  Jade Schrijver; Anke Lenferink; Marjolein Brusse-Keizer; Marlies Zwerink; Paul Dlpm van der Valk; Job van der Palen; Tanja W Effing
Journal:  Cochrane Database Syst Rev       Date:  2022-01-10

3.  Patient-initiated appointment systems for adults with chronic conditions in secondary care.

Authors:  Rebecca Whear; Joanna Thompson-Coon; Morwenna Rogers; Rebecca A Abbott; Lindsey Anderson; Obioha Ukoumunne; Justin Matthews; Victoria A Goodwin; Simon Briscoe; Mark Perry; Ken Stein
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

4.  The costs, resource use and cost-effectiveness of Clinical Nurse Specialist-led interventions for patients with palliative care needs: A systematic review of international evidence.

Authors:  Natalia Salamanca-Balen; Jane Seymour; Glenys Caswell; David Whynes; Angela Tod
Journal:  Palliat Med       Date:  2017-06-28       Impact factor: 4.762

Review 5.  Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations.

Authors:  Andrea Gabrio; Alexina J Mason; Gianluca Baio
Journal:  Pharmacoecon Open       Date:  2017-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.